Literature DB >> 20445560

Parkinson disease: Depression and anxiety in Parkinson disease.

Pablo Martínez-Martín, Javier Damián.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20445560     DOI： 10.1038/nrneurol.2010.49

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

2.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

3.  Anxiety rating scales in Parkinson's disease: critique and recommendations.

Authors:  Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Pablo Martinez-Martin; Irene H Richard; Sergio E Starkstein; Daniel Weintraub; Christina Sampaio; Werner Poewe; Oliver Rascol; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

Review 4.  Review of community prevalence of depression in later life.

Authors:  A T Beekman; J R Copeland; M J Prince
Journal:  Br J Psychiatry       Date:  1999-04       Impact factor: 9.319

Review 5.  Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group.

Authors:  Laura Marsh; William M McDonald; Jeffrey Cummings; Bernard Ravina
Journal:  Mov Disord       Date:  2006-02       Impact factor: 10.338

Review 6.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

Authors:  Maria C Rodriguez-Oroz; Marjan Jahanshahi; Paul Krack; Irene Litvan; Raúl Macias; Erwan Bezard; José A Obeso
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

7.  Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.

Authors:  Laurence Nègre-Pagès; Hélène Grandjean; Maryse Lapeyre-Mestre; Jean Louis Montastruc; Annie Fourrier; Jean Pierre Lépine; Oliver Rascol
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

8.  Use of antidepressants and the risk of Parkinson's disease: a prospective study.

Authors:  A Alonso; L A García Rodríguez; G Logroscino; M A Hernán
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06       Impact factor: 10.154

Review 9.  The prevalence of anxiety in older adults: methodological issues and a review of the literature.

Authors:  Christina Bryant; Henry Jackson; David Ames
Journal:  J Affect Disord       Date:  2007-12-26       Impact factor: 4.839

Review 10.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338
  10 in total
  15 in total

1.  Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Authors:  Leonardo Almeida; Bilal Ahmed; Roger Walz; Sol De Jesus; Addie Patterson; Daniel Martinez-Ramirez; David Vaillancourt; Dawn Bowers; Herbert Ward; Michael S Okun; Nikolaus R McFarland
Journal:  Mov Disord Clin Pract       Date:  2016-06-24

2.  Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Cristian Falup Pecurariu; Per Odin; Jacobus J van Hilten; Angelo Antonini; Jose M Rojo-Abuin; Vanderci Borges; Claudia Trenkwalder; Dag Aarsland; David J Brooks; Kallol Ray Chaudhuri
Journal:  J Neurol       Date:  2012-01-12       Impact factor: 4.849

Review 3.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

4.  Neurobiology of depression and anxiety in Parkinson's disease.

Authors:  Osamu Kano; Ken Ikeda; Derek Cridebring; Takanori Takazawa; Yasuhiro Yoshii; Yasuo Iwasaki
Journal:  Parkinsons Dis       Date:  2011-05-12

5.  Rodent models of Parkinson's disease: beyond the motor symptomatology.

Authors:  Filipa L Campos; Miguel M Carvalho; Ana C Cristovão; Goun Je; Graça Baltazar; António J Salgado; Yoon-Seong Kim; Nuno Sousa
Journal:  Front Behav Neurosci       Date:  2013-11-26       Impact factor: 3.558

6.  Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.

Authors:  Eduard Bentea; Anke Van der Perren; Joeri Van Liefferinge; Anissa El Arfani; Giulia Albertini; Thomas Demuyser; Ellen Merckx; Yvette Michotte; Ilse Smolders; Veerle Baekelandt; Ann Massie
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

7.  Social behavioral changes in MPTP-treated monkey model of Parkinson's disease.

Authors:  Elodie Durand; Odile Petit; Léon Tremblay; Cédric Zimmer; Véronique Sgambato-Faure; Carine Chassain; Marlène Laurent; Bruno Pereira; Céline Silberberg; Franck Durif
Journal:  Front Behav Neurosci       Date:  2015-02-26       Impact factor: 3.558

8.  Non-motor and motor features in LRRK2 transgenic mice.

Authors:  Zoë Bichler; Han Chi Lim; Li Zeng; Eng King Tan
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

Review 9.  The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.

Authors:  A H Ashok; T R Marques; S Jauhar; M M Nour; G M Goodwin; A H Young; O D Howes
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

10.  Hyperbaric oxygen treatment for Parkinson's disease with severe depression and anxiety: A case report.

Authors:  Jin-Jin Xu; Si-Tong Yang; Ying Sha; Yuan-Yuan Ge; Jian-Meng Wang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.